How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030?
Key Points Viking Therapeutics could have a medicine on the market within two years. To capture market share, the new…
Key Points Viking Therapeutics could have a medicine on the market within two years. To capture market share, the new…
Key Points Michael Burry disclosed short positions against Nvidia, Tesla, and Micron in a pair of Substack posts this week.…
Key Points The Shiller CAPE ratio indicates that U.S. stocks are historically expensive right now. The emergence of leveraged single…
Key Points While the analyst backs his bull case with estimates and facts, it’s hard to envision triple-digit percentage gains…
Key Points MercadoLibre’s stock is down due to its declining profit margins. The company is making massive investments in e-commerce…
Key Points Nvidia trades at about 22 times forward earnings, while Coca-Cola trades at about 26 times. Nvidia’s revenue rose…
Macro shifts, rate moves, and the patterns most investors miss — delivered every week before the market opens.
Trusted by portfolio managers, analysts, and independent investors. No spam. Unsubscribe anytime.
Eagle One Intelligence
Macro shifts, market structure, and the ideas worth tracking — straight to your inbox before the crowd figures it out.